BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30616222)

  • 1. Caregiver impact and health service use in high and low severity Dravet syndrome: A multinational cohort study.
    Lagae L; Irwin J; Gibson E; Battersby A
    Seizure; 2019 Feb; 65():72-79. PubMed ID: 30616222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The direct and indirect costs of Dravet Syndrome.
    Whittington MD; Knupp KG; Vanderveen G; Kim C; Gammaitoni A; Campbell JD
    Epilepsy Behav; 2018 Mar; 80():109-113. PubMed ID: 29414539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany.
    Strzelczyk A; Kalski M; Bast T; Wiemer-Kruel A; Bettendorf U; Kay L; Kieslich M; Kluger G; Kurlemann G; Mayer T; Neubauer BA; Polster T; Herting A; von Spiczak S; Trollmann R; Wolff M; Irwin J; Carroll J; Macdonald D; Pritchard C; Klein KM; Rosenow F; Schubert-Bast S
    Eur J Paediatr Neurol; 2019 May; 23(3):392-403. PubMed ID: 30871879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany.
    Strzelczyk A; Schubert-Bast S; Bast T; Bettendorf U; Fiedler B; Hamer HM; Herting A; Kalski M; Kay L; Kieslich M; Klein KM; Kluger G; Kurlemann G; Mayer T; Neubauer BA; Polster T; von Spiczak S; Stephani U; Trollmann R; Wiemer-Kruel A; Wolff M; Irwin J; Carroll J; Pritchard C; Rosenow F
    Epilepsia; 2019 Aug; 60(8):1697-1710. PubMed ID: 31247127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey.
    Campbell JD; Whittington MD; Kim CH; VanderVeen GR; Knupp KG; Gammaitoni A
    Epilepsy Behav; 2018 Mar; 80():152-156. PubMed ID: 29414545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative cross-sectional study of the burden of caring for patients with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex-associated epilepsy in Japan.
    LoPresti M; Igarashi A; Sonohara Y; Bowditch S
    Epilepsy Behav; 2024 May; 154():109741. PubMed ID: 38555725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caregiver perceptions of the impact of Dravet syndrome on the family, current supports and hopes and fears for the future: A qualitative study.
    Soto Jansson J; Bjurulf B; Dellenmark Blom M; Hallböök T; Reilly C
    Epilepsy Behav; 2024 Jul; 156():109790. PubMed ID: 38692022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey.
    Lagae L; Brambilla I; Mingorance A; Gibson E; Battersby A
    Dev Med Child Neurol; 2018 Jan; 60(1):63-72. PubMed ID: 28984349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome.
    Nabbout R; Auvin S; Chiron C; Irwin J; Mistry A; Bonner N; Williamson N; Bennett B
    Epilepsy Behav; 2018 Jan; 78():232-242. PubMed ID: 29108913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future research.
    Jensen MP; Brunklaus A; Dorris L; Zuberi SM; Knupp KG; Galer BS; Gammaitoni AR
    Epilepsy Behav; 2017 May; 70(Pt A):104-109. PubMed ID: 28431364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fenfluramine treatment for Dravet syndrome: Caregiver- and clinician-reported benefits on the quality of life of patients, caregivers, and families living in Germany, Spain, Italy, and the United Kingdom.
    Jensen MP; Gammaitoni AR; Salem R; Wilkie D; Lothe A; Amtmann D
    Epilepsy Res; 2023 Feb; 190():107091. PubMed ID: 36701932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam.
    Strzelczyk A; Schubert-Bast S; Reese JP; Rosenow F; Stephani U; Boor R
    Epilepsy Behav; 2014 May; 34():86-91. PubMed ID: 24727467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures.
    Nabbout R; Auvin S; Chiron C; Thiele E; Cross H; Scheffer IE; Schneider AL; Guerrini R; Williamson N;
    Dev Med Child Neurol; 2019 Oct; 61(10):1229-1236. PubMed ID: 30828793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers.
    Nabbout R; Dirani M; Teng T; Bianic F; Martin M; Holland R; Chemaly N; Coque N
    Epilepsy Behav; 2020 Jul; 108():107094. PubMed ID: 32375095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dravet syndrome: A systematic literature review of the illness burden.
    Strzelczyk A; Lagae L; Wilmshurst JM; Brunklaus A; Striano P; Rosenow F; Schubert-Bast S
    Epilepsia Open; 2023 Dec; 8(4):1256-1270. PubMed ID: 37750463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep quality, anxiety, symptoms of depression, and caregiver burden among those caring for patients with Dravet syndrome: a prospective multicenter study in Germany.
    Maltseva M; Schubert-Bast S; Zöllner JP; Bast T; Mayer T; von Spiczak S; Ruf S; Trollmann R; Wolff M; Hornemann F; Klotz KA; Jacobs J; Kurlemann G; Neubauer BA; Polster T; Syrbe S; Bertsche A; Bettendorf U; Kluger G; Flege S; Rosenow F; Kay L; Strzelczyk A
    Orphanet J Rare Dis; 2023 Apr; 18(1):98. PubMed ID: 37120555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emotional experiences of family caregivers of children with Dravet syndrome.
    Domaradzki J; Walkowiak D
    Epilepsy Behav; 2023 May; 142():109193. PubMed ID: 37028149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social/economic costs and health-related quality of life of mucopolysaccharidosis patients and their caregivers in Europe.
    Péntek M; Gulácsi L; Brodszky V; Baji P; Boncz I; Pogány G; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Iskrov G; Schieppati A; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():89-98. PubMed ID: 27062257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient and Caregiver Health State Utilities in Lennox-Gastaut Syndrome and Dravet Syndrome.
    Lo SH; Lloyd A; Marshall J; Vyas K
    Clin Ther; 2021 Nov; 43(11):1861-1876.e16. PubMed ID: 34774333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social/economic costs and health-related quality of life in patients with Duchenne muscular dystrophy in Europe.
    Cavazza M; Kodra Y; Armeni P; De Santis M; López-Bastida J; Linertová R; Oliva-Moreno J; Serrano-Aguilar P; Posada-de-la-Paz M; Taruscio D; Schieppati A; Iskrov G; Péntek M; von der Schulenburg JM; Kanavos P; Chevreul K; Persson U; Fattore G;
    Eur J Health Econ; 2016 Apr; 17 Suppl 1():19-29. PubMed ID: 27038625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.